Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China · Delayed Price · Currency is CNY 12.46
-0.28 (-2.20%)
May 20, 2026, 11:29 AM CST
SHA:600557 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 299.79 | 303.93 | 391.86 | 464.16 | 434.47 | 320.54 |
Depreciation & Amortization | 185.41 | 185.41 | 199.64 | 194.88 | 189.83 | 187 |
Other Amortization | 13.28 | 13.28 | 5.11 | 5.71 | 3.65 | 4.08 |
Loss (Gain) From Sale of Assets | -0.43 | -0.43 | -0.7 | -0.76 | -1.38 | -0.97 |
Asset Writedown & Restructuring Costs | 1.35 | 1.35 | 1.81 | 2.65 | 0.53 | 2.81 |
Loss (Gain) From Sale of Investments | -10.24 | -10.24 | -20.9 | -14.79 | -4.2 | -4.06 |
Provision & Write-off of Bad Debts | -1.22 | -1.22 | -3.25 | 0.12 | 2.07 | -0.64 |
Other Operating Activities | 31.39 | 38.29 | 31.96 | 5.18 | 8.74 | 13.56 |
Change in Accounts Receivable | 218.94 | 218.94 | 426.77 | 412.01 | -37.18 | 360.36 |
Change in Inventory | 85.55 | 85.55 | -210.9 | -11.65 | -4.22 | 39.92 |
Change in Accounts Payable | -224.45 | -224.45 | -116.94 | -54.92 | 402.82 | -15.23 |
Operating Cash Flow | 599.55 | 610.59 | 702.49 | 972.32 | 995.94 | 908.3 |
Operating Cash Flow Growth | 2.04% | -13.08% | -27.75% | -2.37% | 9.65% | 29.55% |
Capital Expenditures | -612.87 | -521.78 | -476.69 | -311.29 | -211.09 | -171.52 |
Sale of Property, Plant & Equipment | 2.19 | 2.04 | 9.18 | 2.07 | 21.92 | 29.23 |
Divestitures | - | - | 10.25 | - | - | - |
Investment in Securities | 57.43 | -4.36 | 420 | -260.45 | 21.07 | -158.5 |
Other Investing Activities | 12.09 | 10.26 | 22.56 | 14.8 | 4.16 | 4.04 |
Investing Cash Flow | -541.17 | -513.83 | -14.69 | -554.88 | -163.94 | -296.76 |
Short-Term Debt Issued | - | - | 40.67 | - | - | 392 |
Total Debt Issued | - | - | 40.67 | - | - | 392 |
Short-Term Debt Repaid | - | - | - | - | -234.5 | -645.5 |
Long-Term Debt Repaid | - | -0.31 | - | - | - | - |
Total Debt Repaid | -0.31 | -0.31 | - | - | -234.5 | -645.5 |
Net Debt Issued (Repaid) | -0.31 | -0.31 | 40.67 | - | -234.5 | -253.5 |
Issuance of Common Stock | - | - | - | 4.86 | 64.7 | - |
Repurchase of Common Stock | -24.18 | -24.18 | -211.1 | - | - | -180 |
Common Dividends Paid | -91.9 | -91.9 | -213.58 | -128.51 | -2.49 | -11.05 |
Other Financing Activities | - | - | -118.12 | 75.36 | 4 | 1.64 |
Financing Cash Flow | -116.39 | -116.39 | -502.12 | -48.29 | -168.29 | -442.91 |
Foreign Exchange Rate Adjustments | -0.19 | -0.04 | 0.15 | 0.06 | 0.15 | - |
Net Cash Flow | -58.2 | -19.67 | 185.82 | 369.21 | 663.86 | 168.63 |
Free Cash Flow | -13.32 | 88.81 | 225.8 | 661.03 | 784.85 | 736.77 |
Free Cash Flow Growth | - | -60.67% | -65.84% | -15.78% | 6.53% | 44.24% |
Free Cash Flow Margin | -0.41% | 2.70% | 5.79% | 13.59% | 18.04% | 20.19% |
Free Cash Flow Per Share | -0.02 | 0.16 | 0.39 | 1.14 | 1.35 | 1.29 |
Cash Income Tax Paid | 328.51 | 328.51 | 416.7 | 577.46 | 516.83 | 361.61 |
Levered Free Cash Flow | -342.72 | -224.28 | 111.99 | 291.65 | 595.54 | 574.57 |
Unlevered Free Cash Flow | -333.71 | -215.38 | 125.92 | 305.7 | 596.74 | 581.54 |
Change in Working Capital | 80.22 | 80.22 | 96.95 | 315.17 | 362.23 | 385.97 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.